Craig B. Thompson
founder
Pharmaceutics
Agios Pharmaceuticals
United States of America
Biography
Dr. Thompson is an authority in the study of how genes regulate apoptosis and metabolism and investigates their application in treating cancer. His key contributions include: Elucidating the role of the Bcl-2 family of oncogenes role in regulating cell survival Identifying the roles of aerobic glycolysis, fatty acid synthesis and autophagy in the metabolic adaptation by cancer cells as part of carcinogenesis Proposing the concept that most oncogenes and tumor suppressors evolved to regulate cellular metabolism
Research Interest
Elucidating the role of the Bcl-2 family of oncogenes role in regulating cell survival Identifying the roles of aerobic glycolysis, fatty acid synthesis and autophagy in the metabolic adaptation by cancer cells as part of carcinogenesis Proposing the concept that most oncogenes and tumor suppressors evolved to regulate cellular metabolism